Concepedia
Statistics
Publications
6
Citations
541
H-Index
Active since
2003
Affiliations
Stanford University(Current)
California Institute of Technology
Andrew M. Sawayama is an author at Stanford University specializing in drug discovery, medicinal chemistry, and pharmacy.
Publications per year
2003–2019
A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments
Yougen Li, D. Allan Drummond, Andrew M. Sawayama et al. · Nature Biotechnology · 2007 · 164 citations
Life Sciences, Biochemistry, Molecular Biology +10
A Panel of Cytochrome P450 BM3 Variants to Produce Drug Metabolites and Diversify Lead Compounds
Andrew M. Sawayama, Michael M. Y. Chen, Palaniappan Kulanthaivel et al. · Chemistry - A European Journal · 2009 · 146 citations · Full text
Medicine, Pharmacology, Toxicology +15
Discovery of <i>N</i>-(1-Acryloylazetidin-3-yl)-2-(1<i>H</i>-indol-1-yl)acetamides as Covalent Inhibitors of KRAS<sup>G12C</sup>
Youngsook Shin, Joon Won Jeong, Ryan P. Wurz et al. · ACS Medicinal Chemistry Letters · 2019 · 105 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +15
Total Synthesis of Ustiloxin D and Considerations on the Origin of Selectivity of the Asymmetric Allylic Alkylation
Andrew M. Sawayama, Hiroko Tanaka, Thomas J. Wandless · The Journal of Organic Chemistry · 2004 · 47 citations
Natural Sciences, Chemistry, Medicinal Chemistry +16
Enantioselective Total Synthesis of Ustiloxin D
Hiroko Tanaka, Andrew M. Sawayama, Thomas J. Wandless · Journal of the American Chemical Society · 2003 · 45 citations
Pharmacy, Chemistry, Medicinal Chemistry +14
1–5 of 6